J. Allain

发表

Lack of detection of human immunodeficiency virus type 1 DNA by polymerase chain reaction in the plasma and lymphocytes of seronegative exposed hemophiliacs

Y. Laurian, D. Henrard, W. F. Mehaffey, 1993, Transfusion.

Assessment by gene amplification and serological markers of transmission of HIV-1 from hemophiliacs to their sexual partners and secondarily to their children.

I. Hewlett, J. Epstein, Y. Laurian, 1990, Journal of acquired immune deficiency syndromes.

The initial immune response to HIV and immune system activation determine the outcome of HIV disease.

M. Ascher, H. Sheppard, W. Lang, 1991, Journal of acquired immune deficiency syndromes.

Human immunodeficiency virus and human T-cell leukemia virus type I in patients undergoing maintenance hemodialysis in Miami.

H. Lee, E. Parks, J. Bourgoignie, 1989, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Poor sensitivity, specificity, and reproducibility of detection of HIV-1 DNA in serum by polymerase chain reaction. The Transfusion Safety Study Group.

I. Hewlett, M. Busch, J. Epstein, 1992, Journal of acquired immune deficiency syndromes.

A complex human immunodeficiency virus type 1 A/G/J recombinant virus isolated from a seronegative patient with AIDS from Benin, West Africa.

H. Lee, D. Candotti, S. Anagonou, 2001, The Journal of general virology.

The National Cancer Institute phase I study of 2',3'-dideoxyinosine administration in adults with AIDS or AIDS-related complex: analysis of activity and toxicity profiles.

H. Mitsuya, C. Perno, R. Yarchoan, 1990, Reviews of infectious diseases.

Human recombinant single‐chain antibody fragments, specific for the hypervariable region 1 of hepatitis C virus, from immune phage‐display libraries

Shiu-Wan Chan, S. W. Chan, J. Davies, 1999, Journal of viral hepatitis.

Possible Linkage between the Major Histocompatibility Complex and the Immune Response to Factor VIII in Classic Haemophilia

J. Muller, D. Frommel, O. Prou-Wartelle, 1977, Vox sanguinis.

Dominant inheritance of hemophilia A in three generations of women.

H. Gralnick, A. Cederbaum, H. Roberts, 1975, Blood.

The prevalence of antibody to HTLV‐I/II in United States plasma donors and in United States and French hemophiliacs

D. Brettler, G. Leckie, Y. Laurian, 1990, Transfusion.

Effect of zidovudine on serum human immunodeficiency virus core antigen levels. Results from a placebo-controlled trial.

R. Chaisson, P. Volberding, D. Feigal, 1988, Archives of internal medicine.

Antibodies to factor VIII: specificity and kinetics of iso- and hetero-antibodies in hemophilia A.

D. Frommel, J. Allain, 1974, Blood.

A BOARDING SCHOOL FOR HEMOPHILIACS: A MODEL FOR THE COMPREHENSIVE CARE OF HEMOPHILIC CHILDREN

J. Allain, 1975, Annals of the New York Academy of Sciences.

Antibodies to factor VIII. V. Patterns of immune response to factor VIII in hemophilia A.

D. Frommel, J. Allain, 1976, Blood.

ONE OR TWO STAGE ASSAY FOR FACTOR VIII?

J. Soulier, J. Allain, F. Verroust, 1979, The Lancet.

In vitro and in vivo Characterization of Factor VIII Preparations

J. Soulier, J. Allain, F. Verroust, 1980, Vox sanguinis.

A potential new procedure for removing anti-factor VIII antibodies from hemophilic plasma.

C. François-Gérard, G. Brochier, V. Regnault, 1987, Thrombosis Research.

Heterogeneity of autoantibodies to factor VIII: differences in specificity for apparently distinct antigenic determinants of factor VIII coagulant protein.

M. Zuzel, J. Allain, M. Croissant, 1983, Blood.

Absence of anamnestic response after transfusion of washed red blood cells in haemophilia A patients with antibody to factor VIII.

Y. Laurian, M. Larrieu, J. Girma, 2009, Scandinavian journal of haematology.

HLA Antigens and Factor VIII Antibody in Classic Hemophilia

M. Blombäck, P. Mannucci, J. Muller, 1981, Thrombosis and Haemostasis.

Development of factor VIII antibody in haemophilic monozygotic twins. European Study Group of Factor VIII Antibody.

P. Mannucci, Z. Ruggeri, J. Muller, 2009, Scandinavian journal of haematology.

Genetic predisposition to develop factor VIII antibody in classic hemophilia.

D. Frommel, J. Allain, 1977, Clinical immunology and immunopathology.

PRELIMINARY TRIAL OF CYCLOPHOSPHAMIDE IN THE MANAGEMENT OF HEMOPHILIACS WITH FACTOR VIII INHIBITORS *

P. Mannucci, Z. Ruggeri, D. Frommel, 1975, Annals of the New York Academy of Sciences.

Antibodies to factor VIII. I. Variations in stability of antigen-antibody complexes in hemophilia A.

D. Frommel, J. Allain, 1973, Blood.

Clinical Efficacy and Safety of Factor VIII Concentrate

J. Allain, 1984 .

On the unreliability of one-stage factor VIII:C clotting assays after infusion of factor VIII concentrates.

M. Blombäck, K. Schimpf, U. Hedner, 1987, Scandinavian journal of clinical and laboratory investigation.

Screening of selected male blood donors for p24 antigen of human immunodeficiency virus type 1. The Transfusion Safety Study Group.

P. Tomasulo, M. Busch, J. Mosley, 1990, The New England journal of medicine.

Human T-cell leukaemia/lymphoma virus type I infection in West African patients with clinical AIDS.

H. Lee, Y. Adu-Sarkodie, G. Kanmogne, 1998, AIDS.

Human immunodeficiency virus antigenemia in patients with AIDS and AIDS-related disorders: a comparison between European and Central African populations.

A. Goudeau, F. Barin, A. Baillou, 1987, The Journal of infectious diseases.

What Is the Theoretical Basis for the Therapeutic Use of Cryoprecipitates as a Source of Fibronectin?

J. E. Doran, D. Mosher, F. Blumenstock, 1985, Vox sanguinis.

In vivo activity against HIV and favorable toxicity profile of 2',3'-dideoxyinosine.

H. Mitsuya, S. Broder, C. Perno, 1989, Science.

Report of EPFA/NIBSC Workshop ‘Nucleic Acid Amplification Tests (NAT) for the Detection of Blood‐Borne Viruses’ Held on 31 October 1996 in Amsterdam, The Netherlands

J. Saldanha, J. Allain, P. M. Rogers, 1997, Vox sanguinis.

Treatment of the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex with a regimen of 3'-azido-2',3'-dideoxythymidine (azidothymidine or zidovudine) and acyclovir. A pilot study.

H. Mitsuya, M. Leuther, R. Yarchoan, 1988, Annals of internal medicine.

Immune response to HIV p24 core protein during the early phases of human immunodeficiency virus infection.

M. Ascher, H. Sheppard, J. Goudsmit, 1991, AIDS research and human retroviruses.

Prevalence of antibody to hepatitis C virus (HCV) in HIV‐1‐infected patients (nice seroco cohort)

J. Cassuto, J. Allain, P. Dellamonica, 1994, Journal of medical virology.

LONG-LASTING ABATEMENT OF HBsAg SYNTHESIS INDUCED BY ACUTE DELTA INFECTION

M. Rizzetto, A. Couroucé, S. DeRose, 1983, The Lancet.

Molecular genotyping of HIV‐1 in 61 patients with AIDS from Lomé, Togo

H. Lee, E. Timmers, J. Allain, 1999, Journal of medical virology.

Emerging Viruses in Blood Transfusion

J. Allain, 1998, Vox sanguinis.

A Randomized Trial of Solvent/Deter- gent and Standard Fresh Frozen Plasma in the Treatment of theCoagulopathy

J. Neuberger, T. Baglin, L. Williamson, 2013 .

A randomized trial of solvent/detergent‐treated and standard fresh‐frozen plasma in the coagulopathy of liver disease and liver transplantation

J. Neuberger, T. Baglin, L. Williamson, 1999, Transfusion.

Preparation and Clinical Use of New Plasma Protein Concentrates: Antithrombin III and Fibronectin

J. Allain, 1984 .

Virally Inactivated Fresh Frozen Plasma

J. Allain, L. Williamson, J. Allain, 1995, Vox sanguinis.

Detection of TT virus DNA in patients with liver disease and recipients of liver transplant

D. Shang, J. Allain, G. Alexander, 2000, Journal of medical virology.

A prospective study on TT virus infection in transfusion-dependent patients with beta-thalassemia.

A. Zanella, P. Rebulla, G. Sirchia, 1999, Blood.

Hepatitis C virus genomic variability in untreated and immunosuppressed patients.

V. Wong, J. Allain, G. Alexander, 1997, Virology.

Redefining the HIV‐infectious window period in the chimpanzee model: evidence to suggest that viral nucleic acid testing can prevent blood‐borne transmission

J. Allain, K. Murthy, J. Eichberg, 1999, Transfusion.

A comparative study of plateletpheresis using Baxter Autopheresis C and Haemonetics PCS Plus

J. Allain, E. Caffrey, J. Walton, 1994, Transfusion medicine.

A comparison of two supplemental procedures for confirmation of antibody to hepatitis C virus c100–3 antigen in Louisiana blood donors

H. Lee, D. Smith, D. Vallari, 1992, Transfusion.

Transfusion-transmitted HTLV-I/II infection in patients undergoing open- heart surgery

H. Lee, H. Alter, J. Shih, 1990 .

Differential serological diagnosis of HTLV-I and HTLV-II infection by external membrane protein peptide-based enzyme immunoassays.

H. Lee, J. Shih, P. Swanson, 1997, Clinical and diagnostic virology.

Acquired Haemophilia: Functional Study of Antibodies to Factor VIII

D. Frommel, J. Allain, A. Gaillandre, 1981, Thrombosis and Haemostasis.

Cryoprecipitate prepared from plasma virally inactivated by the solvent detergent method

L. Williamson, D. Keeling, D. Keeling, 1997, British journal of haematology.

Immunochemical characterization of antibodies to factor VIII in hemophilic and nonhemophilic patients.

H. Lee, J. Allain, A. Gaillandre, 1981, The Journal of laboratory and clinical medicine.

Non‐A, Non‐B Hepatitis in Hemophilic Patients with Inhibitor Treated with Activated Prothrombin Complex Concentrates: Lack of Correlation with an Antigen Possibly Related to Non‐A, Non‐B Hepatitis

Y. Laurian, C. Gazengel, J. Hellings, 1984, Vox sanguinis.

The Role of HIV Infectivity and Composition of Factor VIII Concentrates on the Immunity of Haemophiliacs Positive for HIV Antibodies

Y. Sultan, C. Gazengel, C. Bosser, 1987, Vox sanguinis.

Factor VIII Procoagulant Antigen in Human Tissues

C. Wolfrom, D. Frommel, J. Allain, 1988, Thrombosis and Haemostasis.

HTLV-1 infection in Brazil.

J. Allain, A. Gonzaga, H. Lee, 1989, Blood.

Transfusion transmission of human T‐lymphotropic virus types I and II: serologic and polymerase chain reaction results in recipients identified through look‐back investigations

S. Kleinman, H. Lee, P. Swanson, 1993, Transfusion.

Hepatic histology in hepatitis C virus carriers coinfected with hepatitis G virus

G. Alexander, D. Wight, J. Petrik, 1998, Gut.

Transfusion-transmitted HTLV-I/II infection in patients undergoing open-heart surgery.

H. Lee, H. Alter, J. Shih, 1990, Blood.

Occurrence of normal circulating proalbumin in a hemophilic A patient after acute hepatitis related to the delta virus.

D. Rochu, J. Fine, J. Allain, 1986, Clinical chemistry.

Rapid isolation and purification of antibody to factor VIII by protein A.

H. Lee, J. Allain, D. Tucker, 1979, Thrombosis research.

Seroepidemiology and clinical aspects of human T-cell lymphotropic virus type I/II infection in a cohort of intravenous drug users in New York City.

H. Lee, L. Brown, T. Nemoto, 1991, New York state journal of medicine.

HIV-1 inhibition by azidothymidine in a concurrently randomized placebo-controlled trail.

R. Makuch, M. Fischl, M. Leuther, 1988, Journal of acquired immune deficiency syndromes.

Immune Response Induced by Porcine Factor VIII in Severe Hemophiliacs with Antibody to F VIII

J. Allain, F. Verroust, 1982, Thrombosis and Haemostasis.

Second-line drugs used in recent-onset rheumatoid arthritis in Brittany (France).

V. Devauchelle, A. Saraux, P. Youinou, 2002, Joint, bone, spine : revue du rhumatisme.

Antibody to HIV-1, HTLV-I, and HCV in three populations of rural Haitians.

M. Einstein, H. Lee, B. Hodges, 1992, Journal of acquired immune deficiency syndromes.

Epidemiological study of latent and recent infection by Toxoplasma gondii in pregnant women from a regional population in the U.K.

C. Palmer, J. Allain, G. Pearson, 1998, The Journal of infection.

Comparative in Vitro and in Vivo Study of Various Factor VIII Preparations

J. Soulier, J. Allain, F. Verroust, 1979, Thrombosis and Haemostasis.

In vitro and in vivo Characterization of Factor VIII Preparations

J. Soulier, J. Allain, F. Verroust, 1980, Vox sanguinis.